FAST NEWS: Clover Bio slumps after booting from China-Hong Kong Stock Connect
The latest: The Shanghai and Shenzhen stock exchanges removed Clover Biopharmaceuticals Ltd. (2197.HK) from their list of securities eligible for trading in the Hong Kong-China Stock Connect program, as part of…
Falling IPO Star: Hong Kong Tipped to Lose Top-Three Ranking Again
Hong Kong is losing some of its luster as an IPO hub, hit by market worries about soaring inflation, rising interest rates, tumbling stock prices and China’s zero-Covid policy. Some…